INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,839 Cr | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr |
What is the latest Revenue of INDEGENE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,839 Cr |
| Mar2024 | ₹2,590 Cr |
| Mar2023 | ₹2,306 Cr |
| Mar2022 | ₹1,665 Cr |
| Mar2021 | ₹966 Cr |
How is Revenue of INDEGENE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,839 Cr | 9.64 | |
| Mar2024 | ₹2,590 Cr | 12.29 | |
| Mar2023 | ₹2,306 Cr | 38.54 | |
| Mar2022 | ₹1,665 Cr | 72.27 | |
| Mar2021 | ₹966 Cr | - | |
Compare Revenue of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,809.8 Cr | 3.3% | -5.5% | -20.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 3.3% |
-5.5% |
-20.5% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses